Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial.

Arabi YM, Asiri AY, Assiri AM, Aziz Jokhdar HA, Alothman A, Balkhy HH, AlJohani S, Al Harbi S, Kojan S, Al Jeraisy M, Deeb AM, Memish ZA, Ghazal S, Al Faraj S, Al-Hameed F, AlSaedi A, Mandourah Y, Al Mekhlafi GA, Sherbeeni NM, Elzein FE, Almotairi A, Al Bshabshe A, Kharaba A, Jose J, Al Harthy A, Al Sulaiman M, Mady A, Fowler RA, Hayden FG, Al-Dawood A, Abdelzaher M, Bajhmom W, Hussein MA; and the Saudi Critical Care Trials group.

Trials. 2020 Jan 3;21(1):8. doi: 10.1186/s13063-019-3846-x.

2.

Implementation of an ACPE-Accredited PharmD Curriculum at a Saudi College of Pharmacy.

Alkatheri AM, Albekairy AM, Khalidi N, Phelps SJ, Gourley DR, Al Jeraisy M, Qandil AM.

Am J Pharm Educ. 2019 Nov;83(9):6237. doi: 10.5688/ajpe6237.

3.

An Evaluation Of Antibiotics Prescribing Patterns In The Emergency Department Of A Tertiary Care Hospital In Saudi Arabia.

Alanazi MQ, Salam M, Alqahtani FY, Ahmed AE, Alenaze AQ, Al-Jeraisy M, Al Salamah M, Aleanizy FS, Al Daham D, Al Obaidy S, Al-Shareef F, Alsaggabi AH, Al-Assiri MH.

Infect Drug Resist. 2019 Oct 16;12:3241-3247. doi: 10.2147/IDR.S211673. eCollection 2019.

4.

Knowledge of and attitudes toward clinical trials in Saudi Arabia: a cross-sectional study.

Al-Rawashdeh N, Damsees R, Al-Jeraisy M, Al Qasim E, Deeb AM.

BMJ Open. 2019 Oct 22;9(10):e031305. doi: 10.1136/bmjopen-2019-031305.

5.

Public motives and willingness to participate in first-in-human clinical trials in Saudi Arabia: A new era in the making.

Almutairi AF, Almutairi BM, Alturki AS, Adlan AA, Salam M, Al-Jeraisy MI, Balkhy HH.

J Infect Public Health. 2019 Sep - Oct;12(5):673-680. doi: 10.1016/j.jiph.2019.03.013. Epub 2019 Apr 18.

6.
7.

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.

Arabi YM, Alothman A, Balkhy HH, Al-Dawood A, AlJohani S, Al Harbi S, Kojan S, Al Jeraisy M, Deeb AM, Assiri AM, Al-Hameed F, AlSaedi A, Mandourah Y, Almekhlafi GA, Sherbeeni NM, Elzein FE, Memon J, Taha Y, Almotairi A, Maghrabi KA, Qushmaq I, Al Bshabshe A, Kharaba A, Shalhoub S, Jose J, Fowler RA, Hayden FG, Hussein MA; And the MIRACLE trial group.

Trials. 2018 Jan 30;19(1):81. doi: 10.1186/s13063-017-2427-0.

8.

Effect of N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan on Opioid Analgesia in Pediatric Intensive Care Unit.

Naeem M, Al Alem H, Al Shehri A, Al-Jeraisy M.

Pain Res Manag. 2016;2016:1658172. Epub 2016 Oct 27.

9.

Attitude, barriers and facilitators to practice-based research: cross-sectional survey of hospital pharmacists in Saudi Arabia.

Sultana K, Al Jeraisy M, Al Ammari M, Patel R, Zaidi ST.

J Pharm Policy Pract. 2016 Feb 11;9:4. doi: 10.1186/s40545-016-0052-z. eCollection 2016.

10.

Severity scores and their associated factors among orally poisoned toddlers: a cross sectional single poison center study.

Alanazi MQ, Al-Jeraisy M, Salam M.

BMC Pharmacol Toxicol. 2016 Jan 4;17:1. doi: 10.1186/s40360-015-0044-7.

11.

Comparative outcome analysis of home-initiated non-medical interventions among toddlers with orally ingested substances.

Alanazi MQ, Al-Jeraisy MI, Salam M.

Ital J Pediatr. 2015 Sep 15;41:63. doi: 10.1186/s13052-015-0170-2.

12.

Prevalence and predictors of antibiotic prescription errors in an emergency department, Central Saudi Arabia.

Alanazi MQ, Al-Jeraisy MI, Salam M.

Drug Healthc Patient Saf. 2015 Jun 4;7:103-11. doi: 10.2147/DHPS.S83770. eCollection 2015.

13.

Chloral hydrate versus midazolam as sedative agents for diagnostic procedures in children.

Hijazi OM, Ahmed AE, Anazi JA, Al-Hashemi HE, Al-Jeraisy MI.

Saudi Med J. 2014 Feb;35(2):123-31.

PMID:
24562510
14.

Drug treatment of inborn errors of metabolism: a systematic review.

Alfadhel M, Al-Thihli K, Moubayed H, Eyaid W, Al-Jeraisy M.

Arch Dis Child. 2013 Jun;98(6):454-61. doi: 10.1136/archdischild-2012-303131. Epub 2013 Mar 26. Review.

15.

Medication prescribing errors in a pediatric inpatient tertiary care setting in Saudi Arabia.

Al-Jeraisy MI, Alanazi MQ, Abolfotouh MA.

BMC Res Notes. 2011 Aug 14;4:294. doi: 10.1186/1756-0500-4-294.

16.

Public attitude towards biomedical research at outpatient clinics of King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Al-Jumah M, Abolfotouh MA, Alabdulkareem IB, Balkhy HH, Al-Jeraisy MI, Al-Swaid AF, Al-Musaaed EM, Al-Knawy B.

East Mediterr Health J. 2011 Jun;17(6):536-45.

17.

Antibiotic prescribing in a pediatric emergency setting in central Saudi Arabia.

Mohajer KA, Al-Yami SM, Al-Jeraisy MI, Abolfotouh MA.

Saudi Med J. 2011 Feb;32(2):197-8. No abstract available.

PMID:
21301771
18.

Recurrent visits and admissions of children with asthma in central Saudi Arabia.

Al-Yami SM, Mohajer KA, Al-Jeraisy MI, Batarfi AM, Abolfotouh MA.

Saudi Med J. 2010 Aug;31(8):921-4.

PMID:
20714693
19.

Intraventricular vancomycin in pediatric patients with cerebrospinal fluid shunt infections.

Al-Jeraisy M, Phelps SJ, Christensen ML, Einhaus S.

J Pediatr Pharmacol Ther. 2004 Jan;9(1):36-42. doi: 10.5863/1551-6776-9.1.36.

Supplemental Content

Loading ...
Support Center